An Act to Prohibit Interference with the Professional Judgment and Clinical Decisions of Licensed Health Care Professionals as Recommended by the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State
LD 2199 would create a new prohibition against any person directly or indirectly interfering with, controlling, or directing the professional judgment or clinical decisions of a licensed health care professional with independent practice authority when that professional is providing services at or through a health care entity. The bill defines “health care entity” broadly to include health care providers, facilities, and provider organizations, while excluding nursing facilities. It also defines “health care facility,” “health care provider,” and “provider organization” for purposes of the new section.
The bill specifies examples of prohibited interference, including dictating the amount of time spent with patients, the number of patients seen, discharge timing, clinical-status decisions such as observation status or palliative care, diagnosis and billing-code choices, diagnostic testing decisions, and other clinical decision-making that the Department determines is intended to interfere with professional judgment. The measure is described as implementing a recommendation from the Commission to Evaluate the Scope of Regulatory Review and Oversight over Health Care Transactions That Impact the Delivery of Health Care Services in the State.
If enacted, LD 2199 would add a new state-law restriction affecting employers, health systems, provider organizations, and other entities operating health care settings in Maine. It would protect licensed health care professionals with independent practice authority from managerial or institutional pressure that crosses into clinical decision-making, potentially affecting staffing practices, discharge protocols, documentation and coding policies, and operational oversight in hospitals, clinics, and other facilities. The bill would also give the Department a role in identifying additional conduct that constitutes prohibited interference.
The available record suggests the bill was introduced as a policy recommendation from a commission rather than as a measure with clear support or opposition already established in committee. The committee report explicitly states that the Joint Standing Committee on Health Coverage, Insurance and Financial Services took no position on the substance of the bill and was advancing it only to allow for public hearing and normal legislative processing. No vote history or committee testimony is provided, so there is no documented partisan or stakeholder sentiment in the record supplied.
The central point of contention is likely to be the boundary between legitimate administrative oversight and prohibited interference with clinical judgment. Health care employers and systems may be concerned that the bill could limit their ability to manage patient flow, discharge planning, documentation standards, coding practices, and utilization controls, while health care professionals and patient advocates may support the bill as a safeguard against pressure that could compromise patient care. The bill’s broad definitions and the Department’s authority to identify additional prohibited conduct may also raise questions about scope and enforcement.